UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 23, 2020
GENERAL CANNABIS CORP
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Colorado |
|
000-54457 |
|
90-1072649 |
(State or other jurisdiction
|
|
(Commission File Number) |
|
(I.R.S. Employer Identification Number) |
|
|
|
6565 E. Evans Avenue
|
|
80224 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (303) 759-1300
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange
|
N/A |
|
N/A |
|
N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Item 5.02 Compensatory Arrangements of Certain Officers
On November 23, 2020, the shareholders of General Cannabis Corp (the “Company”), upon recommendation of the Board of Directors of the Company (the “Board”), approved the General Cannabis Corp 2020 Omnibus Incentive Plan (the “2020 Plan”) at the 2020 annual meeting of shareholders (the “2020 Annual Meeting”).
The 2020 Plan became effective immediately upon approval by the Company’s shareholders and will expire on November 23, 2030, unless terminated earlier by the Board. The 2020 Plan will permit the Board, or a committee or subcommittee thereof, to grant to eligible employees, non-employee directors and consultants of the Company and its subsidiaries non-statutory and incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units, deferred stock units, performance awards, non-employee director awards, and other stock-based awards. Subject to adjustment, the maximum number of shares of the Company’s common stock to be authorized for issuance under the 2020 Plan is 10,000,000 shares.
The foregoing summary of the 2020 Plan does not purport to be complete and is qualified in its entirety by reference to the text of the 2020 Plan, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. A more detailed summary of the 2020 Plan can be found in the Company’s Definitive Proxy Statement on Schedule 14A for the Company’s 2020 Annual Meeting filed with the Securities and Exchange Commission on October 21, 2020.
Item 5.03 Amendments to Articles of Incorporation or Bylaws.
On November 23, 2020, the Company’s shareholders, upon recommendation of the Board, approved an amendment to the Company’s Amended and Restated Articles of Incorporation at the Company’s 2020 Annual Meeting.
The amendment to the Company’s Amended and Restated Articles of Incorporation was filed with the Secretary of State of the State of Colorado on November 23, 2020 and increased the aggregate number of shares of common stock that the Company has the authority to issue from 100,000,000 shares of common stock to 200,000,000 shares.
A copy of the Amendment to the Amended and Restated Articles of Incorporation is attached hereto as Exhibit 3.1.
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the Company’s 2020 Annual Meeting held on November 23, 2020, the Company’s shareholders voted on five proposals and cast their votes as described below. The proposals are set forth in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on October 21, 2020.
Proposal 1. The Company’s shareholders elected five (5) nominees to the board of directors, each to hold office for a one-year term and until the 2021 annual meeting or until his successor is duly elected and qualified, based on the following votes:
Proposal 2. The Company’s shareholders approved, on an advisory basis, the Company’s named executive officer compensation, based on the following votes:
|
|
|
|
|
|
|
For |
|
Withheld |
|
Abstain |
|
Broker Non-Votes |
18,879,901 |
|
1,301,954 |
|
163,816 |
|
27,333,341 |
Proposal 3. The Company’s shareholders approved an amendment to the Company’s Amended and Restated Articles of Incorporation that increases the aggregate number of shares of common stock that the Company has the authority to issue from 100,000,000 shares of common stock to 200,000,0000 shares, based on the following votes:
|
|
|
|
|
|
|
For |
|
Withheld |
|
Abstain |
|
Broker Non-Votes |
36,369,489 |
|
10,891,798 |
|
417,725 |
|
-- |
Proposal 4. The Company’s shareholders approved the General Cannabis Corp 2020 Omnibus Incentive Plan, based on the following votes:
|
|
|
|
|
|
|
For |
|
Withheld |
|
Abstain |
|
Broker Non-Votes |
18,776,012 |
|
1,413,551 |
|
156,108 |
|
27,333,341 |
Proposal 5. The Company’s shareholders ratified the appointment of Marcum, LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2020, based on the following votes:
|
|
|
|
|
|
|
For |
|
Withheld |
|
Abstain |
|
Broker Non-Votes |
44,553,174 |
|
912,124 |
|
2,213,714 |
|
-- |
Item 9.01 Financial Statement and Exhibits
(d)Exhibits
|
|
Exhibit No. |
Description |
3.1 |
Amendment to Amended and Restated Articles of Incorporation effective November 23, 2020 |
10.1 |
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: November 25, 2020
|
|
|
|
GENERAL CANNABIS CORP |
|
|
|
|
|
|
|
|
By: |
/s/ Steve Gutterman |
|
Name: |
Steve Gutterman |
|
Title: |
Chief Executive Officer |
Exhibit 3.1
GENERAL CANNABIS CORP
Articles of Amendment
Pursuant to the provisions of Title 7 of the Colorado Revised Statutes of the State of Colorado, General Cannabis Corp, a Colorado corporation, does hereby amend its Amended and Restated Articles of Incorporation.
Article IV – Capital Stock
The aggregate number of shares of stock which this Corporation shall have authority to issue is Two Hundred Five Million (205,000,000) shares, consisting of Two Hundred Million (200,000,000) shares of common stock, $0.001 par value (the “Common Stock”), and Five Million (5,000,000) shares of preferred stock, no par value (the “Preferred Stock”), which may be issued in one or more series at the discretion of the Board of Directors. In establishing a series of Preferred Stock, the Board of Directors shall give to it a distinctive designation so as to distinguish it from the shares of all other series and classes, shall fix the number of shares in such series, and the preferences, rights and restrictions thereof. All shares of any one series shall be alike in every particular expect as otherwise provided by these Articles of Incorporation or the Colorado Business Corporation Act.
In witness whereof, the corporation, by and through its undersigned officer thereunto duly authorized, has executed these Articles of Amendment on November 23, 2020.
GENERAL CANNABIS CORP
By: /s/ Steve Gutterman
Name: Steve Gutterman
Title: Chief Executive Officer
Exhibit 10.1
GENERAL CANNABIS CORP
2020 OMNIBUS INCENTIVE PLAN
TABLE OF CONTENTS
1.Purpose of Plan.3
2.Definitions.3
3.Plan Administration.7
4.Shares Available for Issuance.9
5.Participation.10
6.Options.10
7.Stock Appreciation Rights.11
8.Restricted Stock Awards, Restricted Stock Units and Deferred Stock Units.12
9.Performance Awards.14
10.Non-Employee Director Awards.15
11.Other Stock-Based Awards.15
12.Dividend Equivalents.16
13.Effect of Termination of Employment or Other Service.16
14.Payment of Withholding Taxes.18
15.Change in Control.19
16.Rights of Eligible Recipients and Participants; Transferability.21
17.Securities Law and Other Restrictions.22
18.Deferred Compensation; Compliance with Section 409A.23
19.Amendment, Modification and Termination.23
20.Substituted Awards.24
21.Effective Date and Duration of this Plan.24
22.Miscellaneous.24
GENERAL CANNABIS CORP
2020 OMNIBUS INCENTIVE PLAN
1. | Purpose of Plan. |
The purpose of the General Cannabis Corp 2020 Omnibus Incentive Plan (this “Plan”) is to advance the interests of General Cannabis Corp, a Colorado corporation (the “Company”), and its stockholders by enabling the Company and its Subsidiaries to attract and retain qualified individuals to perform services for the Company and its Subsidiaries, providing incentive compensation for such individuals that is linked to the growth and profitability of the Company and increases in stockholder value and aligning the interests of such individuals with the interests of its stockholders through opportunities for equity participation in the Company.
2. | Definitions. |
The following terms will have the meanings set forth below, unless the context clearly otherwise requires. Terms defined elsewhere in this Plan will have the same meaning throughout this Plan.
3. | Plan Administration. |
4. | Shares Available for Issuance. |
5. | Participation. |
Participants in this Plan will be those Eligible Recipients who, in the judgment of the Committee, have contributed, are contributing or are expected to contribute to the achievement of the objectives of the Company or its Subsidiaries. Eligible Recipients may be granted from time to time one or more Awards, singly or in combination or in tandem with other Awards, as may be determined by the Committee in its sole discretion. Awards will be deemed to be granted as of the date specified in the grant resolution of the Committee, which date will be the Grant Date of any related Award Agreement with the Participant.
6. | Options. |
7. | Stock Appreciation Rights. |
8. | Restricted Stock Awards, Restricted Stock Units and Deferred Stock Units. |
9. | Performance Awards. |
10. | Non-Employee Director Awards. |
11. | Other Stock-Based Awards. |
12. | Dividend Equivalents. |
Subject to the provisions of this Plan and any Award Agreement, any Participant selected by the Committee may be granted Dividend Equivalents based on the dividends declared on shares of Common Stock that are subject to any Award (including any Award that has been deferred), to be credited as of dividend payment dates, during the period between the date the Award is granted and the date the Award is exercised, vests, settles, is paid or expires, as determined by the Committee. Such Dividend Equivalents will be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Committee and the Committee may provide that such amounts (if any) will be deemed to have been reinvested in additional shares of Common Stock or otherwise reinvested. Notwithstanding the foregoing, the Committee may not grant Dividend Equivalents based on the dividends declared on shares of Common Stock that are subject to an Option or Stock Appreciation Right or unvested Performance Awards; and further, no dividend or Dividend Equivalents will be paid out with respect to any unvested Awards.
13. | Effect of Termination of Employment or Other Service. |
14. | Payment of Withholding Taxes. |
15. | Change in Control. |
16. | Rights of Eligible Recipients and Participants; Transferability. |
17. | Securities Law and Other Restrictions. |
18. | Deferred Compensation; Compliance with Section 409A. |
It is intended that all Awards issued under this Plan be in a form and administered in a manner that will comply with the requirements of Section 409A of the Code, or the requirements of an exception to Section 409A of the Code, and the Award Agreements and this Plan will be construed and administered in a manner that is consistent with and gives effect to such intent. The Committee is authorized to adopt rules or regulations deemed necessary or appropriate to qualify for an exception from or to comply with the requirements of Section 409A of the Code. With respect to an Award that constitutes a deferral of compensation subject to Code Section 409A: (a) if any amount is payable under such Award upon a termination of service, a termination of service will be treated as having occurred only at such time the Participant has experienced a Separation from Service; (b) if any amount is payable under such Award upon a Disability, a Disability will be treated as having occurred only at such time the Participant has experienced a “disability” as such term is defined for purposes of Code Section 409A; (c) if any amount is payable under such Award on account of the occurrence of a Change in Control, a Change in Control will be treated as having occurred only at such time a “change in the ownership or effective control of the corporation or in the ownership of a substantial portion of the assets of the corporation” as such terms are defined for purposes of Code Section 409A, (d) if any amount becomes payable under such Award on account of a Participant’s Separation from Service at such time as the Participant is a “specified employee” within the meaning of Code Section 409A, then no payment will be made, except as permitted under Code Section 409A, prior to the first business day after the earlier of (i) the date that is six months after the date of the Participant’s Separation from Service or (ii) the Participant’s death, and (e) no amendment to or payment under such Award will be made except and only to the extent permitted under Code Section 409A.
19. | Amendment, Modification and Termination. |
20. | Substituted Awards. |
The Committee may grant Awards under this Plan in substitution for stock and stock-based awards held by employees of another entity who become employees of the Company or a Subsidiary as a result of a merger or consolidation of the former employing entity with the Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the former employing corporation. The Committee may direct that the substitute Awards be granted on such terms and conditions as the Committee considers appropriate in the circumstances.
21. | Effective Date and Duration of this Plan. |
This Plan is effective as of the Effective Date. This Plan will terminate at midnight on the day before the ten (10) year anniversary of the Effective Date, and may be terminated prior to such time by Board action. No Award will be granted after termination of this Plan, but Awards outstanding upon termination of this Plan will remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of this Plan.
22. | Miscellaneous. |